Loading data
CELCNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 145 m USD | 104.2 m USD | 60.59 m USD | 35.29 m USD | 25.76 m USD |
| Operating profit | -172.19 m USD | -113.27 m USD | -66.23 m USD | -39.39 m USD | -28.36 m USD |
| Interest expense | — | — | 5.33 m USD | 2.11 m USD | 1.26 m USD |
| Profit before tax | -177.04 m USD | -111.78 m USD | -63.78 m USD | -40.37 m USD | -29.61 m USD |
| Net income (reported basis) | -177.04 k USD | -111.78 k USD | -63.78 k USD | -40.37 k USD | -29.61 m USD |
| Basic earnings per share | -3.79 USD/share | -2.83 USD/share | -2.69 USD/share | -2.64 USD/share | -2.21 USD/share |
| Diluted earnings per share | -3.79 USD/share | -2.83 USD/share | -2.69 USD/share | -2.64 USD/share | — |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.